등록된 논문 166건

※ 클릭시 해당 논문페이지로 이동합니다.

• N/A위암

  Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

  • 저널 Gastric Cancer. 2018 Sep;21(5):819-830.
  • 제1저자 정민규
  • 교신저자 라선영, 조재용

• KCSG HN15-16두경부식도암분과

  Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma

  • 저널 Cancer Res Treat. 2019 Jan; 51(1): 300-312.
  • 제1저자 임선민, 조상희, 황인규
  • 교신저자 윤환중, 김상우, 김혜련

• KCSG BR10-04유방암분과

  Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study).

  • 저널 Eur J Cancer. 2018 Nov;103:127-136.
  • 제1저자 김지연
  • 교신저자 임영혁

• KCSG LU12-13폐암분과

  A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13

  • 저널 Cancer Res Treat. 2019 Apr;51(2):718-726.
  • 제1저자 유쾌한
  • 교신저자 안명주

• KCSG PC13-02완화의료

  Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients

  • 저널 Support Care Cancer. 2017 Dec;25(12):3759-3767.
  • 제1저자 오소연
  • 교신저자 신상원

• KCSG CO14-03대장암

  A Randomized Phase II Trial of Consolidation Chemotherapy after Preoperative Chemoradiation versus Chemoradiation alone for Locally Advanced Rectal Cancer: KCSG CO 14-03

  • 저널 Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):889-899
  • 제1저자 김선영
  • 교신저자 백지연

• KCSG PC13-09완화의료

  Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.

  • 저널 Br J Cancer.2018 May;118(9):1169-1175.
  • 제1저자 김진원
  • 교신저자 김지현

• KCSG LU12-07폐암

  Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07).

  • 저널 Br J Cancer. 2018 Mar 6;118(5):648-653.
  • 제1저자 선종무
  • 교신저자 안명주

• KCSG BR11-01유방암

  Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

  • 저널 Cancer Res Treat. 2019 Jan;51(1):43-52.
  • 제1저자 박인혜
  • 교신저자 노정실

• KCSG CO12-04대장암

  The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean
  Cancer Study Group CO12-04 study.

  • 저널 Korean J Intern Med. 2019 Jan;34(1):165-177.
  • 제1저자 변재호
  • 교신저자 박영석

1112131415